Thanks to research, the last four decades has witnessed an increased comprehension of the etiology, clinical manifestations, and psychopathology of schizophrenia spectrum disorders. More so, the introduction of modern antipsychotics has aided the potential for recovery from schizophrenia and other psychosis disorders.This paper is a study guide forChlorpromazine, a psychotropic agent for treating patients with Schizophrenia Spectrum and Other Psychotic Disorders. Description of the Psychopharmacological medication agent including brand and generic names and appropriate FDA indication uses Chlorpromazine(the generic name) is a psychotropic agent sold under brand names such as ThorazineandLargactil.
3 The FDA indications for Chlorpromazine include the following: Schizophrenia - positive symptoms Bipolar I acute manic type Nausea and vomiting Acute agitation - explosive hyperexcitable behavior Chronic hiccups Adjust treatment of tetanus Acute intermittent porphyria Relief of apprehension before surgery (Mann & Marwaha, 2023). Non-FDA uses Off-label adjust treatment of serotonin syndrome and migraine associated relief of vomiting and nausea (Mann & Marwaha, 2023). Drug classification Chlorpromazinebelongs to the class of drugs referred to as typical antipsychotics, first- generation antipsychotics, or neuroleptic medication category. Typical or first-generation
Order this paper